Quoin Pharmaceuticals, Ltd. - Ordinary Shares (QNRX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2025 to Q4 2025

Type / Class
Equity / Ordinary Shares
Symbol
QNRX on Nasdaq
Shares outstanding
30,615,414
Price per share
$14.43
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
1,491
Total reported value
$10,716
% of total 13F portfolios
0%
Share change
-1,046
Value change
-$9,379
Number of holders
4
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Quoin Pharmaceuticals, Ltd. - Ordinary Shares (QNRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Stonepine Capital Management, LLC 9.9% $62,800,787 3,030,926 Stonepine Capital Management, LLC 10 Dec 2025
INTEGRATED CORE STRATEGIES (US) LLC 9% $13,673,537 1,901,585 Integrated Core Strategies (US) LLC 20 Oct 2025
ARMISTICE CAPITAL, LLC 5% $5,784,329 1,081,183 Armistice Capital, LLC 31 Mar 2025
Ikarian Capital, LLC 25% $4,383,067 211,538 Ikarian Capital, LLC 30 Nov 2025
Resolute Capital Asset Partners LLC 8.5% $1,036,000 50,000 Resolute Capital Asset Partners LLC 10 Oct 2025

As of 30 Sep 2025, 4 institutional investors reported holding 1,491 shares of Quoin Pharmaceuticals, Ltd. - Ordinary Shares (QNRX). This represents 0% of the company’s total 30,615,414 outstanding shares.

Institutional Holders of Quoin Pharmaceuticals, Ltd. - Ordinary Shares (QNRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 77,084 $1,112,322 +$1,108,310 $14.43 2
2025 Q3 1,491 $10,716 -$9,379 $7.09 4
2025 Q2 2,537 $23,400 +$22,428 $9.23 6
2025 Q1 108 $24 +$24 $0.22 1